<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the effect of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> on cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> as well as the expression of nuclear fac for (NF-kappaB) p65 in the experimental permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model was constructed in 20 Wistar rats with Longa's method </plain></SENT>
<SENT sid="2" pm="."><plain>Then the 20 rats were divided into 4 groups: control group, and 3 resveratrol groups (<z:chebi fb="0" ids="27881">resveratrol</z:chebi> of the concentrations of 10(-8) g/kg, 10(-7) g/kg, and 10(-6) g/kg were injected intravenously) (group 1- 4) </plain></SENT>
<SENT sid="3" pm="."><plain>The area of <z:mpath ids='MPATH_124'>infarct</z:mpath> was examined by 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) staining </plain></SENT>
<SENT sid="4" pm="."><plain>The water content was calculated by dry and wet weight method </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of NF-kappaB p65 was investigated with immunohistochemistry </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The ischemic volume was 241 +/- 36, 222 +/- 39, 126 +/- 16, and 128 +/- 19 * in the groups 1 - 4 respectively, and the volume ratio was 0.49 +/- 0.04, 0.47 +/- 0.04, 27 +/- 0.02, and 0.43 +/- 0.02 respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The brain water content was 83.5% +/- 1.5%, 82.9% +/- 1.4%, 79.5% +/- 1.5%, and 79.9% +/- 1.4% in groups 1 - 4 with a significant difference between 10(-7) g/kg <z:chebi fb="0" ids="27881">resveratrol</z:chebi> group and pure <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group and 10(-6) g/kg <z:chebi fb="0" ids="27881">resveratrol</z:chebi> group and pure <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group (both P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>NF-kappaB p65 was not expressed in the <z:mpath ids='MPATH_458'>normal</z:mpath> control group and sham operation group, and was expressed 2 hours after pure <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The expression of NF-kappaB p65 positive cells was the most significant 12 hours after the pure <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and began to decrease 24 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="27881">Resveratrol</z:chebi> has a neuroprotective effect on the ischemic brain </plain></SENT>
<SENT sid="11" pm="."><plain>This effect is related to the inhabitation of expression of NF-kappaB p65 </plain></SENT>
</text></document>